Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 serologic response and pneumococcal nasal carriage in HIV-positive adults
2011-004518-40Phase 3Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Mar 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoint: Serological response after two doses of PCV13. Started Mar 2012; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2011-004518-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004518-40.